ArticleMedicine2025
Hemorrhagic cardiac tamponade complicating myocardial infarction in a hemodialysis patient with essential thrombocythemia: A case report.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
rationaleHemopericardium, the accumulation of blood within the pericardial sac, can lead to fatal cardiac tamponade if untreated. Its subtle presentation often obscures classic tamponade signs, complicating timely diagnosis. Essential thrombocythemia (ET), a chronic myeloproliferative neoplasm, predisposes patients to both thrombotic and hemorrhagic complications. While aspirin is effective in reducing thrombotic risks associated with ET, it can also precipitate life-threatening bleeding, such as hemorrhagic cardiac tamponade. PATIENT CONCERNS: A 71-year-old hemodialysis-dependent woman with ET experienced worsening dyspnea and chest tightness 1 month after starting dual antiplatelet therapy. This therapy was initiated immediately following a percutaneous coronary intervention for an acute non-ST elevation myocardial infarction. DIAGNOSES: Computed tomography revealed a massive pericardial effusion, and echocardiography confirmed cardiac tamponade. Ultrasound-guided pericardiocentesis yielded hemorrhagic fluid, establishing the diagnosis of hemorrhagic cardiac tamponade.
interventionsPericardiocentesis resolved the effusion, but recurrent non-ST elevation myocardial infarctions and in-stent restenosis necessitated repeated balloon angioplasty. OUTCOMES: Discontinuation of aspirin and the addition of cilostazol to clopidogrel failed to prevent further complications. The patient later developed pulse ventricular tachycardia in the emergency department, and after her family declined cardioversion, she died. LESSONS: This case exemplifies the complex challenges of managing thrombotic and hemorrhagic risks in ET patients with cardiovascular disease and renal impairment, highlighting the necessity for tailored therapeutic strategies and further research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.